10.09.26 -- ICH M4Q(R2) And M16 Modernize The CTD For Digital Submissions

Pharma and biotech developers rely on adaptable fill‑finish capacity to meet evolving market demands, scale products from clinical to commercial, and respond rapidly to public‑health emergencies.

Early design alignment resolves tolerance stack-ups, controls mechanical variation, and maintains sample accuracy. Navigating process validation accelerates commercialization.

Modernize visual inspection workflows by linking qualification records directly to real-time scheduling tools, eliminating compliance risks and manual record-keeping drift.

Preserving data context across bioanalytical workflows improves decision-making, ensures complete traceability, speeds up study review cycles, and prepares datasets for advanced AI.

Product recalls are becoming a major concern in life sciences. Learn why your company must act now to strengthen quality systems and reduce risk across pharmaceuticals, devices, and biologics.

Structure‑enabled drug discovery revealed a novel, druggable binding site in Artemis, enabling rapid SAR optimization and a ~500‑fold potency improvement against a challenging oncology target.

Paper-heavy production can slow decisions and limit flexibility. See how IT/OT integration connects shop-floor and enterprise data to support real-time visibility and more resilient operations.

Consistent absorption across different formulations and dietary conditions ensures stable therapeutic exposure. This flexibility simplifies patient dosing schedules and supports manufacturing transitions.

Explore strategies to improve the performance of IB processes as well as the pros and cons of soluble and insoluble processes: isolating, solubilizing, and properly refolding.

Aligning visual inspection systems with site standards prevents costly validation failures. Discover strategies to de-risk equipment startup.

As China expands its role in drug development, injectable therapy programs face new demands. Gain insight into how manufacturers are scaling quality, devices, and production for global success.

Accelerate recombinant protein development from sequence to scale while maintaining stable expression, manufacturing efficiency, and critical quality attributes.

Standardized, continuously optimized facility design enables scalable biomanufacturing that improves quality, accelerates timelines, and ensures consistent performance across sites.

GMP compliance requires monitoring microbial contamination levels in cleanrooms and clean spaces. It is important to know the role active air samplers play in this process and parameters for evaluating them.

As manufacturing becomes more flexible and decentralized, sterile connection choices matter more than ever. Delve into how portable and fixed tube welders compare and how each supports sterility.

Understand how high shear and planetary mixing technologies optimize adhesive production. Reduce cycle times, eliminate defects, and balance efficiency with your specific viscosity needs.